These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1755709)

  • 1. [Antimicrobial activity of piperacillin in vitro].
    Skala LZ; Nekhorosheva AG; Nasonov VN; Prokhorova VA
    Antibiot Khimioter; 1991 Aug; 36(8):39-42. PubMed ID: 1755709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinico-bacteriological evaluation of the effectiveness of piperacillin in suppurative-inflammatory diseases of the lungs and pleura].
    Skala LZ; Nasonov VN; Nekhorosheva AG; Savitskaia KI; Dutova EN
    Antibiot Khimioter; 1992 Jun; 37(6):27-8. PubMed ID: 1417340
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
    Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
    Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative antibacterial activity of piperacillin against Pseudomonas aeruginosa, Escherichia coli and Streptococcus faecalis in cultures and human serum].
    Just HM; Reiber T; Bassler M; Daschner FD
    Immun Infekt; 1985 May; 13(3):119-23. PubMed ID: 3924819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro activity of netilmicin against 357 clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus.
    Digranes A; Dibb WL; Ostervold B
    Scand J Infect Dis Suppl; 1980; Suppl 23():30-3. PubMed ID: 6782655
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics.
    Friedland I; Mixson LA; Majumdar A; Motyl M; Woods GL
    J Chemother; 2002 Oct; 14(5):483-91. PubMed ID: 12462428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins.
    Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH; Jones RN
    J Antibiot (Tokyo); 1977 Dec; 30(12):1098-106. PubMed ID: 599083
    [No Abstract]   [Full Text] [Related]  

  • 8. Multicenter in vitro comparison of piperacillin and nine other antibacterials against 1,629 clinical isolates.
    Greenberg RN; Bowne DB; Gelfand M; Sathe SS
    Clin Ther; 1990; 12(1):61-70. PubMed ID: 2183941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cefoperazone against clinical isolates of Enterobacteriaceae, Pseudomonas and Staphylococcus.
    Olarte J
    Clin Ther; 1980; 3(Spec Issue):130-3. PubMed ID: 6446386
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations on Staphylococcus aureus and Pseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes.
    Bassler M; Depuis W; Utz E; Just HM; Daschner FD
    Eur J Clin Microbiol; 1983 Oct; 2(5):439-44. PubMed ID: 6416838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
    Roland RK; Mendes RE; Silbert S; Bolsoni AP; Sader HS
    Braz J Infect Dis; 2000 Oct; 4(5):226-35. PubMed ID: 11063554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of netilmicin.
    Hussain Qadri SM; Johnson S
    J Okla State Med Assoc; 1984 Jul; 77(7):198-201. PubMed ID: 6432977
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the serum bactericidal activity of ceftriaxone/piperacillin and ceftriaxone/netilmicin.
    Machka K; Röbl M; Braveny I
    Eur J Clin Microbiol; 1986 Feb; 5(1):115-8. PubMed ID: 3084240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibility patterns of selected bacterial isolates in a general hospital in Kuwait.
    Dhar R; Marafi E
    J Trop Med Hyg; 1991 Apr; 94(2):111-5. PubMed ID: 2023287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.
    Thornsberry C; Baker CN; Barry AL; Jones RN
    Clin Ther; 1980; 3(Spec Issue):39-45. PubMed ID: 6446397
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions of antimicrobial combinations in vitro: the relativity of synergism.
    Blaser J
    Scand J Infect Dis Suppl; 1990; 74():71-9. PubMed ID: 2129067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers.
    Barry AL; Jones RN; Ayers LW; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1984 May; 25(5):669-71. PubMed ID: 6732234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the antibacterial activity in vitro of cement-antibiotic mixtures.
    Greco F; Rossi A; De Palma L; Spagnolo N
    Ital J Orthop Traumatol; 1981 Apr; 7(1):103-13. PubMed ID: 6799427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
    Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
    Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibilities of bacteria against chemotherapeutics under different conditions.
    Arai T
    Keio J Med; 1977 Jan; 26(1):31-42. PubMed ID: 926525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.